Office Hours with Senator Richard Burr
Webcast series on legislative developmentsEssential Insights for Navigating the Evolving Legislative Landscape.
Office Hours with Senator Richard Burr offers valuable guidance on understanding the evolving legal and regulatory landscape in response to the current presidential administration. Utilizing Senator Burr's extensive experience, this webcast series provides a unique opportunity to gain insider knowledge on Capitol Hill developments.
To learn more about our Regulatory and Government Affairs experience, visit dlapiper.com or contact Che Webb.
Upcoming Sessions
This series is responsive to legislative news and headlines while focusing on topics* impacting companies today.
All sessions begin at 1:30 pm ET
- Nov 17 - Breaking Down the Latest DC Developments*
- Dec 1 - Essential Updates from the Hill*
- Dec 15 - Looking Ahead to 2026*
*Topics subject to change
November 3 Recap
The ongoing government shutdown creates uncertainty for organizations, making proactive planning around policy changes, funding opportunities, and cybersecurity essential.
Key actions
- Empower congressional champions to drive your legislative priorities forward.
- Track regulatory proposals and leverage emerging investment opportunities.
- Enhance cybersecurity measures and employee training before the 2026 election cycle.
To gain access to the recording of this conversation, reach out to Che Webb.
Session Takeaways
Senator Burr and the panel focused on the ongoing government shutdown and the broader implications for trade, AI legislation, and cybersecurity in 2026.
Key Takeaways:
- There are no signs of imminent resolution, with the shutdown potentially extending to Thanksgiving or even Christmas, driven by deep divisions over ACA subsidies and lack of active negotiations.
- The debate is both ideological and geographical, with enhanced subsidies and earnings limits at the heart of the dispute, and insurers notably silent on the issue.
- Despite the shutdown, markets remain strong, trade deals are progressing, and the average American has not felt significant disruption, which is unusual compared to past shutdowns.
- Congress is expected to move slowly on AI regulation, aiming for minimal guardrails to avoid stifling investment and innovation, learning from Europe’s experience with over-regulation.
- Companies should prioritize cyber hygiene and employee education, as AI-driven cyberattacks are expected to escalate, especially during the upcoming election cycle.
To gain access to the recording of this conversation, reach out to Che Webb.
Senator Richard Burr and hosts covered the government shutdown’s effects and evolving U.S. trade policies, especially tariffs and their impact on business and offered guidance for organizations facing policy uncertainty.
Key Takeaways:
- The shutdown may last, causing permanent layoffs and agency disruption.
- Tariffs are used for negotiation, foreign policy, and revenue, with a focus on bilateral deals.
- Businesses need stronger compliance and flexible supply chains to manage changing rules.
- Drug pricing is targeted through direct negotiations and new programs, with ongoing uncertainty.
- Tariffs will likely remain, so companies must engage policymakers and adapt strategies.
To gain access to the recording of this conversation, reach out to Che Webb.
This Office Hours session features Senator Burr and Representative Charlie Dent discussing the high likelihood of a government shutdown, its political dynamics, and the impact on federal agencies, healthcare, and business. The conversation also covers current healthcare controversies and the challenges of misinformation in public discourse.
Key Takeaways
- Shutdown Likely: Both parties are entrenched, making a government shutdown almost certain and potentially lengthy.
- Economic & Agency Impact: Shutdowns disrupt FDA reviews, NIH grants, and business investment, with long-term costs and operational delays.
- Healthcare Policy Fights: Major debates center on ACA subsidies, Medicaid cuts, and pharmaceutical pricing, with pressure on Congress to resolve funding and policy issues.
- Science vs. Politics: Controversies around CDC, FDA, and direct-to-consumer drug advertising highlight tensions between scientific guidance and political influence.
- Misinformation Risks: Social media-driven misinformation is seen as a major threat, increasing public confusion and political division.
To gain access to the recording of this conversation, reach out to Che Webb.
